# AEGIS-01 — RESEARCH CYCLE 14 EXECUTION PLAN
## Prospective Implementation: Dynamic Arterial Hemostasis & Multilayer Acoustic Wave Dispersion

**Program:** AEGIS-01 (Integrated Biological Defense Direction of SUBJECT-01)  
**Parent Repository:** `G1F12/SUBJECT-01` | **Local Directory:** `D:\AEGIS-01`  
**Date of Adoption:** 2026-11-12  
**Planning Horizon:** Research Cycle 14  
**Document ID:** `AEGIS-DOC-C14-PLAN-001`  
**Governing Decision:** [`DEC-0074`](file:///d:/AEGIS-01/registry/decisions.json)  
**Status:** Approved Operational Research Plan

---

## 1. Executive Summary & Selection Rationale

In strict accordance with Strategic Roadmap 2.0 governance rules, active research in Cycle 14 is restricted to a **maximum of two prioritized hypotheses**. All candidate directions were evaluated against six rigorous selection criteria:

| Candidate Research Track | Direct Impact on Survival | Independent Data Availability | Testability of Prediction | Scale of Remaining Uncertainty | Whole-Organism Compatibility | Expected Information Value | Prioritization Decision |
| :--- | :---: | :---: | :---: | :---: | :---: | :---: | :---: |
| **Track 1: Dynamic Arterial Vasospasm & Hemostatic Shear Limits (`HYP-0051`)** | **CRITICAL** (Prevents lethal exsanguination in seconds) | **HIGH** (Porcine arterial transection & microfluidic shear trials) | **HIGH** (Analytical & numerical fluid-structure interaction) | **HIGH** (Shear dislodgement threshold currently uncoupled in trauma) | **HIGH** (Integrates directly into `SYS-04` and `SYS-07`) | **MAXIMUM** (Resolves acute fatal bottleneck in combat trauma) | **SELECTED (PRIORITY 1)** |
| **Track 2: Viscoelastic Multilayer Acoustic Stress Dispersion (`HYP-0052`)** | **CRITICAL** (Prevents lethal Behind-Armor Blunt Trauma & commotio cordis) | **HIGH** (Ultrasonic bio-tissue impedance & PMHS ballistic databases) | **HIGH** (1D/2D elastodynamic finite-difference wave solver) | **HIGH** (Multi-interface wave reflection unquantified in biohybrid skin) | **HIGH** (Couples `SYS-01`, `SYS-02`, and `SYS-04`) | **HIGH** (Replaces rigid armor with passive stratified biological damping) | **SELECTED (PRIORITY 2)** |
| **Track 3: Scale Array Contact Mechanics & Reverse-Shear Penetration** | MODERATE (Local puncture defense) | MODERATE (Dry pangolin scale compression only) | MODERATE (Requires nonlinear contact FEM) | MODERATE (Kinematic bounds established in Cycle 13) | MODERATE (Increases distal segment inertia) | MODERATE (Marginal gains over analytical kinematics) | **TRANSFERRED TO MAINTENANCE** |
| **Track 4: Hierarchical Multi-Level Keratin Law (Hoof/Horn)** | LOW (Narrow material property) | HIGH (Kasapi & Gosline 1997 hoof datasets) | HIGH (Mori-Tanaka composite homogenization) | LOW (Physics well understood; fails on hoof due to cross-tissue diversity) | LOW (Does not alter whole-organism survivability) | LOW (High effort for specialized polymer mechanics) | **TRANSFERRED TO MAINTENANCE** |
| **Track 5: Multi-Muscle Synergist Deconvolution for VML** | MODERATE (Long-term recovery) | LOW (Independent labs use divergent injury models) | LOW (Multi-species pooling is methodologically invalid) | VERY HIGH (Requires in-house animal surgeries) | LOW (Recovery occurs over weeks/months, not CPE45) | LOW (Prior audit established `INSUFFICIENT_DATA`) | **TRANSFERRED TO MAINTENANCE** |

---

## 2. Priority Track 1: Dynamic Arterial Vasospasm & Hemostatic Shear (`HYP-0051`)

### 2.1 Scientific Objective & Hypothesis Statement
- **Statement (`HYP-0051`):** In penetrating arterial trauma, autonomous hemostasis without external compression is physically impossible above a critical wall shear stress threshold $\tau_{\text{crit}} \in [15, 35]\text{ Pa}$, because flow-induced hydrodynamic drag forces exceed platelet fibrin mesh tensile anchor strength. Stable thrombus formation requires active longitudinal vasoconstriction ($r_{\text{lumen}} / r_0 < 0.35$ over segment length $L > 10\text{ mm}$) to depress wall shear below $\tau_{\text{crit}}$.
- **Primary Deliverables in Cycle 14:**
  1. `aegis/cycle14_hemostasis.py`: Coupled dynamic fluid-structure interaction (FSI) model linking vascular smooth muscle contraction kinetics, Navier-Stokes shear stress, platelet deposition kinetics, and closed-loop cardiac preload depletion.
  2. `tests/test_cycle14_hemostasis.py`: Test suite validating conservation of mass, critical shear bounding, and time-to-hemostasis against porcine femoral transection literature.
  3. `HEMODYNAMIC_SHEAR_VALIDATION.md`: Technical report detailing the derivation, stability proofs, and validation against independent microfluidic platelet studies (Nesbitt et al. 2009).

### 2.2 Independent Validation Datasets
- **Dataset A:** Nesbitt et al. (2009), *Nature Medicine* 15(6):665–673 — Microfluidic shear-dependent platelet aggregation thresholds ($15\text{--}35\text{ Pa}$).
- **Dataset B:** Kauvar, Lefering, & Wade (2006), *J. Trauma* 60(6 Suppl):S3–S11 — Clinical and large-animal arterial hemorrhage rates and survival curves.

---

## 3. Priority Track 2: Viscoelastic Multilayer Acoustic Stress Dispersion (`HYP-0052`)

### 2.1 Scientific Objective & Hypothesis Statement
- **Statement (`HYP-0052`):** Stratified biological tissue architectures with alternating acoustic impedance ($Z_{\text{keratin}} \approx 2.86\text{ MRayl} \to Z_{\text{dermis}} \approx 1.84\text{ MRayl} \to Z_{\text{adipose}} \approx 1.38\text{ MRayl} \to Z_{\text{fascia}} \approx 1.71\text{ MRayl}$) dissipate incident high-rate kinetic stress waves through multiple internal reflections and viscoelastic hysteresis, attenuating transmitted peak thoracic wall acceleration by $>25\%$ compared to a homogeneous soft-tissue baseline and reducing peak Viscous Criterion ($VC_{\max}$) below lethal thresholds ($<0.6\text{ m/s}$).
- **Primary Deliverables in Cycle 14:**
  1. `aegis/cycle14_ballistics.py`: 1D/2D elastodynamic wave propagation engine resolving compressive and shear stress wave transmission across stratified bio-interfaces with frequency-dependent attenuation ($\alpha(f) \propto f^n$).
  2. `tests/test_cycle14_ballistics.py`: Unit tests verifying acoustic energy conservation, boundary reflection/transmission coefficients, and Viscous Criterion attenuation.
  3. `ACOUSTIC_ENERGY_DISSIPATION.md`: Technical report detailing the stress wave dispersion proofs and comparison against Bass et al. (2006) and Roberts et al. (2007) Behind-Armor Blunt Trauma data.

### 2.2 Independent Validation Datasets
- **Dataset A:** Duck, F. A. (1990), *Physical Properties of Tissue: A Comprehensive Reference Book* — Ultrasonic sound speed, density, and acoustic impedance across mammalian tissues.
- **Dataset B:** Bass, C. R. et al. (2006), *Int. J. Occup. Saf. Ergon.* 12(4):393–404 — Post-mortem human subject (PMHS) behind-armor thoracic impact velocity and deflection datasets.

---

## 4. Formal Transition to MAINTENANCE Status

The following research tracks are formally closed to active model expansion and transferred to `MAINTENANCE`:

1. **Keratin Glass Transition & Hydration Modeling:**
   - *Rationale:* Following the Cycle 12 audit, the boundaries of linear heuristics vs. the Fox plasticization equation and cross-tissue domain failures (equine hoof wall) are fully characterized. No further progress is possible without proprietary lab crystallization data. Code remains frozen and maintained for regression stability.
2. **Imbricated Scale Kinematic Geometry:**
   - *Rationale:* Analytical equations for overlap pitch ($p$), dermal gap strain ($\epsilon_{\text{gap}}$), jamming angles ($\theta_{\text{jam}}$), and minimum bend radii ($R_{\min}$) were fully derived and harmonized in Cycle 13. Reverse-shear vulnerabilities are established. Further 3D contact FEM is deferred until whole-organism dynamics are resolved.
3. **Volumetric Muscle Loss Acellular Bioscaffold Priors:**
   - *Rationale:* Cycle 12 and 13 audits confirmed that literature priors are confounded by synergist load sharing, and acellular scaffolds provide $0\%$ active force recovery in isolated muscle. Designated `INSUFFICIENT_DATA` until independent cell-seeded vascular niche data becomes available.

---

## 5. Execution Timeline & Governance Checkpoints

- **Days 1–3:** Formulate governing differential equations for closed-loop FSI arterial spasm and elastodynamic multilayer stress propagation.
- **Days 4–7:** Implement simulation engines in `aegis/cycle14_hemostasis.py` and `aegis/cycle14_ballistics.py`.
- **Days 8–10:** Construct comprehensive test suites in `tests/test_cycle14_*.py` and execute verification.
- **Days 11–13:** Author technical reports `HEMODYNAMIC_SHEAR_VALIDATION.md` and `ACOUSTIC_ENERGY_DISSIPATION.md`.
- **Day 14:** Update permanent registries (`registry/*.json`), synchronize with PR #9 worktree, and verify CI status.
